Delivery Order SPE2DE24D0013-SPE2D625F3DZG
- Not listed
- The U.S. Defense Department's Medical Supply Chain agency awarded a $7,700 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based molecular diagnostics manufacturer, on September 3, 2025, with an ultimate completion date of September 10, 2025. This delivery order, designated as XPRSARS-COV2-10, carries no set-aside designation and represents procurement of diagnostic solutions from Cepheid's established portfolio of molecular testing systems. The...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The award, issued on July 30, 2025, with an ultimate completion date of August 6, 2025, carries no set-aside designation and covers diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. Performance will take place at...
- The Defense Department's Medical Supply Chain awarded a $57.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 8, 2025, for molecular diagnostic solutions with an ultimate completion date of September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, will be performed in Sunnyvale, California, where Cepheid manufactures its GeneXpert diagnostic systems and associated test kits. This award carries no set-aside designation and represents a continuation of...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, pertains to XPCOV2/FLU/RSV-10 testing capabilities and carries no set-aside designation. The contract represents work performed under Cepheid's larger indefinite delivery vehicles,...
- The Defense Department's Medical Supply Chain has awarded a $24,088.95 delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on July 14, 2025, with an ultimate completion date of July 21, 2025, represents procurement under Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. The delivery order designation...
- The U.S. Defense Health Agency, through the Medical Supply Chain, awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 12, 2025, for molecular diagnostic solutions with an ultimate completion date of August 19, 2025. This delivery order, designated 4569068770 and titled XPCOV2/FLU/RSV-10, leverages Cepheid's expertise in infectious disease diagnostics and carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale,...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,913.79 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 13, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The contract is structured as a delivery...
- On August 8, 2025, the Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $10,200 to Cepheid Inc. (UEI: W6HQTMWB9Q28) for molecular diagnostic solutions. The delivery order, identified as XPRS4PLEX-10 with contract number 4569031069, requires completion by August 15, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation and represents a continuation of...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,815.72 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on June 27, 2025, for completion by July 7, 2025. The delivery order, identified as XPRSMVP-10, will be performed in Sunnyvale, California, and carries no set-aside designation. Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, specializes in advanced diagnostic systems and test kits for infectious diseases, genetic...
- The Defense or Civilian agency within Medical Supply Chain awarded a $5,775 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on July 22, 2025, with an ultimate completion date of July 29, 2025. This contract, identified as XPRSARS-COV2-10, involves delivery of molecular diagnostic solutions to the Sunnyvale, California location. The award carries no set-aside designation and represents a delivery order against one of Cepheid's existing Indefinite Delivery Vehicle contracts...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3DZGDelivery Order
The U.S. Department of Defense Medical Supply Chain awarded a $2,117.50 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 11, 2025, for SARS-COV-2+ testing supplies. The contract, with an ultimate completion date of September 25, 2025, will be performed in Sunnyvale, California, where Cepheid maintains its headquarters. This delivery order was issued without a set-aside designation, reflecting open and competitive procurement practices. The award represents continued fulfillment of the Department of Defense's molecular diagnostic testing requirements through Cepheid's established federal contracting relationship. Cepheid is a specialized manufacturer of molecular diagnostic solutions that provides test kits and diagnostic systems to multiple federal agencies, including the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency. The company holds significant indefinite delivery contracts with the VA, including a $32.8 million IDV with VA's Veterans Integrated Service Network 6 and a $2.5 million IDV with Veterans Integrated Service Network 21, both supporting comprehensive molecular diagnostic testing for infectious diseases. This delivery order award aligns with Cepheid's core business of supplying COVID-19, influenza, and respiratory diagnostic testing capabilities to the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/11/25 |